|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Consolidated net loss | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Employee stock compensation expense | |||||
| Changes in deferred taxes | |||||
| Provision for expected credit losses | |||||
| Amortization of debt issuance costs and original issue discount | |||||
| Noncash interest and accretion expense | |||||
| Loss on fair value remeasurement of embedded derivative | |||||
| Other non-cash operating activities | |||||
| Gain on debt extinguishment | |||||
| Goodwill impairment loss | |||||
| Non-cash amortization of inventory fair value step-up | |||||
| Non-cash restructuring costs | |||||
| Changes in operating assets and liabilities: | |||||
| Trade receivables and contract assets | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Operating lease right-of-use assets and liabilities, net | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Fees invoiced in advance | |||||
| Other asset and liabilities, net | |||||
| Net cash (used in) provided by operating activities | |||||
| Investing activities: | |||||
| Capital expenditures | |||||
| Proceeds from sale of property and equipment | |||||
| Cash paid for other investing activities | |||||
| Cash paid for acquisitions | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Payments of long-term debt | |||||
| Payments of debt issuance costs | |||||
| Payments on promissory notes | |||||
| Payments on revolving credit facility | |||||
| Payments on senior term notes and delayed draw term loans | |||||
| Borrowings on revolving loan facility | |||||
| Issuance of second lien notes | |||||
| Issuance of common shares | |||||
| Borrowings on delayed draw term loans | |||||
| Proceeds from exercise of stock options | |||||
| Other financing activities, net | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Noncash financing activity: | |||||
| Non-cash debt issuance costs | |||||
| Seller financed acquisition | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Income taxes paid, net | |||||
Loading...